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Giardiasis, currently considered a neglected disease, is caused by the intestinal
protozoan parasiteGiardia duodenalis and is widely spread in human as well as domestic
and wild animals. The lack of appropriate medications and the spread of resistant
parasite strains urgently call for the development of novel therapeutic strategies. Host
microbiota or certain probiotic strains have the capacity to provide some protection
against giardiasis. By combining biological and biochemical approaches, we have been
able to decipher a molecular mechanism used by the probiotic strain Lactobacillus
johnsonii La1 to preventGiardia growth in vitro. We provide evidence that the supernatant
of this strain contains active principle(s) not directly toxic to Giardia but able to
convert non-toxic components of bile into components highly toxic to Giardia. By
using bile acid profiling, these components were identified as deconjugated bile-salts.
A bacterial bile-salt-hydrolase of commercial origin was able to mimic the properties of
the supernatant. Mass spectrometric analysis of the bacterial supernatant identified two
of the three bile-salt-hydrolases encoded in the genome of this probiotic strain. These
observations document a possible mechanism by which L. johnsonii La1, by secreting, or
releasing BSH-like activity(ies) in the vicinity of replicatingGiardia in an environment where
bile is present and abundant, can fight this parasite. This discovery has both fundamental
and applied outcomes to fight giardiasis, based on local delivery of deconjugated bile
salts, enzyme deconjugation of bile components, or natural or recombinant probiotic
strains that secrete or release such deconjugating activities in a compartment where
both bile salts and Giardia are present.
Keywords: giardiasis, lactobacilli, probiotics, microbiota, bile salts, anti-giardial activity, choloylglycine bile acid
hydrolase
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INTRODUCTION
Giardia duodenalis is a parasitic protozoa responsible for
giardiasis, a disease characterized by acute or chronic intestinal
malabsorption, diarrhea, weight loss, dehydration, and
abdominal pain in humans and a variety of vertebrates. It
is one of the most common intestinal parasites, with 200–300
million human cases estimated worldwide per year (Lane
and Lloyd, 2002). Giardiasis has high veterinary impact and
high impact on public health, and is responsible for human
morbidity, especially causing nutritional deficiencies in children
in developing countries (Lane and Lloyd, 2002; Ali andHill, 2003;
Veenemans et al., 2011). Developed countries are also concerned
by giardiasis; outbreaks have been associated with drinking water
contamination resulting from runoff of contaminated soils by
rain falls, agricultural practices, and sewage treatment plant
dysfunctions (Mons et al., 2009; Baldursson and Karanis, 2011).
Giardia duodenalis exists under two development forms, a
resistant form called cyst, responsible for the transmission of
the parasite between vertebrate hosts, and an active form called
trophozoite, that replicates within intestinal tracts of hosts.
Cysts enter vertebrate hosts via several routes such as food,
water, or fomites contaminated by feces from infected hosts.
Cysts remain infective for months in environmental waters and
are infectious at low doses (10–100 cysts; Lane and Lloyd,
2002). Upon parasite excystation, newly formed trophozoites are
released and colonize the surface of the intestinal barrier in the
upper small intestine (duodenum). The duodenum constitutes a
very specific microenvironment where chyme from the stomach,
bile produced from the liver and stored in the gall bladder, and
digestive enzymes from the pancreas pour in. After encystation
in the lower part of the small intestine, parasites exit the host in
the feces (Lane and Lloyd, 2002; Ali and Hill, 2003; Ankarklev
et al., 2010).
The pathophysiology of giardiasis is multifactorial and
comprises damages to the host’s mucosal surface such as diffuse
microvillous shortening and a reduction of villus-crypt ratios.
An increase of epithelial permeability, which might lead to a
bacterial translocation is also observed as well as an impairment
of disacharridase activity of digestive enzymes (Cotton et al.,
2011; Buret et al., 2015). These changes may be due as much to
factors of the host as to those of the parasite. In recent studies,
a post-infectious link has been established between Giardia
infection and intestinal- and extra-intestinal disorders such as
inflammatory bowel syndrome and chronic fatigue syndrome
(Halliez and Buret, 2013; Ventura et al., 2004). The drug of choice
for treating giardiasis remains metronidazole, a 5-nitroimidazole
(Leitsch et al., 2011). However, drug side effects (vertigo, nausea,
vomiting, anorexia, and dizziness; Gardner and Hill, 2001) and
the occurrence of drug resistant strains (Upcroft and Upcroft,
2001; Lalle, 2010; Tian et al., 2010; Ansell et al., 2015) make
research on alternative therapeutic strategies necessary.
Abbreviations: BSH, bile salt hydrolase; GC, glycocholate; GCDC,
glycochenodeoxycholate; GDC, glycodeoxycholate; KM, TYI-S-33 Keiser’
medium; KM-FCS, KM with fetal calf serum; MTYI, modified TYI-S-33; NEFA,
non-esterified fatty acids; TC, taurocholate; TCDC, taurochenodeoxycholate;
TDC, taurodeoxycholate.
In this context, it is now widely recognized that the intestinal
microbiota plays a role in the protection of the host against
the gut colonization by pathogens (Singer and Nash, 2000;
Travers et al., 2011; Kamada et al., 2013; Bartelt and Sartor,
2015). Different mechanisms may be responsible for these
protective effects such as competition for pathogen ecological
niches, competition for nutritional substrates, production of
antimicrobial compounds, and enhancement of the innate and
adaptive host immune responses (Tancrède, 1992; Kamada et al.,
2013). Works highlighted the importance of intestinal bacteria
in G. duodenalis infection (Singer and Nash, 2000). Evidence
suggests that the bacterium Enterococcus faecium contributes to
the clearance of G. duodenalis by enhancing the host immune
response (Benyacoub et al., 2005). Additionally, the probiotic
bacterium Lactobacillus johnsonii La1 antagonizes G. duodenalis
establishment in rodent models (Humen et al., 2005) and
extracellular factors of L. johnsonii La1 arrest the in vitro
growth of G. duodenalis in the G1 phase indicating that this
bacterium may directly affect parasite replication (Pérez et al.,
2001). A better knowledge of the molecular interactions between
G. duodenalis and the duodenal microbiota could thus open new
chemotherapeutic strategies based on the inhibition of specific
parasite enzymes or processes. L. johnsonii La1 constitutes a
model of choice to study the molecular crosstalks between
G. duodenalis and probiotic bacteria such as lactobacilli, which
are one of the most common bacteria in the duodenum. Anti-
Giardia activity was clearly demonstrated in vivo and in vitro
(Pérez et al., 2001; Humen et al., 2005) and the genomes
of L. johnsonii La1 and G. duodenalis have been sequenced
(Pridmore et al., 2004; Morrison et al., 2007; Franzén et al., 2009).
In the present paper, we investigated the molecular
mechanisms involved in the in vitro anti-Giardia activity
of extracellular factors of the probiotic L. johnsonii La1.
G. duodenalis can be cultured in vitro (Keister, 1983). Bile was
historically added into Giardia culture medium to promote its
in vitro growth, even if this gain in generation time could be
reduced at high bile and bile salt concentrations (Farthing et al.,
1983, 1985). Parasites can internalize bile lipids as metabolites
or source of phospholipids for membrane biosynthesis (Farthing
et al., 1985; Halliday et al., 1995; Das et al., 1997). Conjugated
bile salts have also a role in promoting encystation (Gillin,
1987; Gillin et al., 1989). We found that the parasite growth
inhibition by L. johnsonii La1 culture spent supernatant is
mediated by secreted bacteria bile-salt hydrolase-like activity(ies)
that generate(s) deconjugated bile salts from bile present in
the culture medium. Unlike conjugated bile salts, the main
components of bile, deconjugated bile salts were found to be
toxic to Giardia.
MATERIALS AND METHODS
Products and Preparation of Stock
Solutions
Bovine bile (reference B3883, Sigma-Aldrich and reference
212820, Difco, BD Diagnostic Systems) was prepared
at 100mg/ml stock solution in distilled water, sterilized
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through 0.2µm filters and stored at −20◦C. Pure bile salts:
glycocholate (GC), taurocholate (TC), glycodeoxycholate
(GDC), taurodeoxycholate (TDC), glycochenodeoxycholate
(GCDC), and taurochenodeoxycholate (TCDC), bile salt mix
or pure deconjugated bile salts: cholate (C), deoxycholate (DC),
and chenodeoxycholate (CDC), and fusidic acid were from
Sigma-Aldrich and dissolved in distilled water to 12 mg/ml stock
solutions, filtered through 0.2µm pores and kept at −20◦C.
Choloylglycine Bile Acid Hydrolase or Bile Salt Hydrolase (BSH,
EC 3.5.1.24) from Clostridium perfringens (reference C4018,
Sigma-Aldrich) was prepared at 10U/ml in distilled water and
stored at −20◦C. Fetal calf serum (FCS, reference A15-101, PAA
Laboratories, GE Healthcare), and bovine calf serum (reference
B9433, Sigma-Aldrich) were used. The NEFA-C kit used for
quantitative determination of non-esterified fatty acids (NEFAs)
was from Biolab, WAKO Diagnostics.
Cell Culture of Giardia duodenalis
Trophozoites of G. duodenalis strains WB (clone C6, ATCC
30957) and HP1 (Portland-1, gift of Jan Tackezy, Charles
University of Prague, Czech Republic) from assemblage A were
routinely maintained in axenic culture in TYI-S-33 Keister’s
medium (KM) as previously described (Keister, 1983). Parasites
were grown in 15ml tubes filled with 12ml culture medium.
They were regularly subcultured at a density of 5 × 104 cells per
tube (12ml) from log phase parasites chilled on ice for 10min
and centrifuged at 700 × g, 5min. For bioassays, parasites were
maintained in culture in KM adjusted to pH 6.0, supplemented
with 10% heat-inactivated FCS (Paget et al., 2004) and 0.6 g/L
bovine bile (Carnaby et al., 1994).
Culture of Lactobacillus johnsonii La1 and
Production of Bacterial Supernatant
L. johnsonii La1 (CNRZ 1897, NCC533) was kindly provided
by Pascal Quénée (INRA Jouy en Josas, Equipe Atalis, France)
and was isolated from LC1 product in 1996 (Chambourcy,
France). The presence of L. johnsonii La1 prophage, as previously
described (Ventura et al., 2004; Denou et al., 2008), was checked
by PCR using two primer pairs: 1DF/1B2R resulting in a 1500
bp amplicon for L. johnsonii “La1-like” (with the prophage)
and 1EF/1B2R resulting in a 268 bp amplicon as a positive
control for L. johnsonii strains. PCR reactions were run in a final
volume of 25µl containing 200 ng of bacterial DNA extracted
with a standard protocol (Zhong et al., 1998), 200 nM of each
primer (1DF: AGA CTT TTT GGC AGG CAA AGG, 1EF:
ACA AAC CAC CAG TGC CTA AGG, 1B2R: GCT CTT CGA
GAT CAC TGG GC), 200 nM of dNTP, and 1U of Taq DNA
polymerase (NEB M0273S). Reactions were initiated with an
initial denaturation for 5min at 95◦C followed by 35 cycles at
95◦C for 30 s, 50◦C for 30 s and 72◦C for 1min. PCR products
were visualized on 0.8% agarose gel containing 0.5 ng/µl of BET
and images were captured with a camera coupled with Biocapt
software, Vilber Lourmat.
L. johnsonii La1 stock cultures were kept frozen in de
Man Rogosa Sharpe (MRS) Broth (Sigma-Aldrich) media with
15% glycerol. Bacteria were subcultured in MRS or modified
TYI-S-33 medium (MTYI) (Pérez et al., 2001) and incubated
anaerobically for 12–18 h at 37◦C. Bacteria were subsequently
grown in MTYI or KM supplemented with or without 10%
heat-inactivated FCS for 12–16 h in the presence or the
absence of 0.6 g/L bovine bile. After centrifugation (3000 ×
g, 10min) and 0.2 µm filtration, the pH of the L. johnsonii
La1 supernatant was adjusted to 6.0 with 5 N NaOH. For
some experiments, pH was adjusted to 6.2, 6.7, 6.9, or 7.2.
Appropriated controls were prepared as follows: lactic acid
produced during growth was quantified from aliquots of
supernatants (EnzytecTM kit, R-Biopharm) and an equivalent
amount of lactic acid was added to fresh medium before pH
adjustment.
In vitro G. duodenalis Growth Inhibition
Assay
One milliliter of trophozoite suspension (1 × 105 parasites/ml
in KM, pH 6, supplemented with 10% FCS without bovine bile)
was mixed with either 500µl of L. johnsonii La1 supernatant
or one, or two, units of commercial bile salt hydrolase (BSH)
from C. perfringens, chromatography purified fractions or
appropriate control medium. These suspensions were further
mixed with different concentrations of either bovine bile,
mixed bile salts, conjugated, or deconjugated bile salts or
appropriate control medium. Samples were then incubated
for 24 h at 37◦C and chilled on ice for 10min to dislodge
trophozoites from tube wall. Trophozoites were counted
using a Malassez cell chamber and were considered alive
when parasites showed the typical pear shape and signs of
flagella mobility (Video S1). Morphologically altered parasites
with non-mobile flagella were considered “dead” (Video S2).
Estimates of parasite viability on these criteria correlate with
parasite viability measured by propidium iodide staining and
flow cytometry analysis (Barbosa et al., 2008; Figure S1).
Multiplication factor [i.e., number of total trophozoites
at the end of the experiment/number of trophozoites at
time zero], survival rate [i.e., (number of living cells/total
number of trophozoites) × 100], and inhibition percentage
[i.e., (100-number of living cells in the presence of tested
compounds/number of living cells in control) × 100] were
calculated.
Partial Purification of Active Fractions from
L. johnsonii La1 Supernatants by Gel
Filtration
Supernatants from L. johnsonii La1 cultures in KM, adjusted
to pH 6.0, were concentrated up to 30-fold by ultrafiltration
using the 10 kDa Centriprep centrifugal filter unit (Millipore).
After 0.2µm filtration, the concentrated supernatants were
loaded onto a Sephacryl S300 column 16/100 (GE Healthcare),
previously equilibrated with 20mM ammonium sulfate (pH
6.0), in a cold room and were eluted with the same buffer
at a flow rate of 2.0ml/min. Eﬄuent fractions of 12 ml
were collected, concentrated 4-fold by ultrafiltration on a
10 kDa Centriprep and tested for in vitro Giardia growth
inhibition in the presence of bovine bile or bile salts.
Fractions obtained by similar processing of elution buffer alone
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and control media containing lactic acid (see above) were
used as controls. Column calibration was carried out with
ribonuclease A (13.7 kDa) and bovine serum albumin (67
kDa).
Characterization of the Inhibitory
Molecule(s) in L. johnsonii La1 Supernatant
The molecular size of inhibitory molecule(s) present in
L. johnsonii La1 supernatant was assessed by ultrafiltration
using 10, 30, and 50 kDa Centriprep centrifugal filter
units. Thermal stability was tested by heating the bacterial
supernatant to 90◦C for 10min. Preservation of L. johnsonii
La1 supernatant activity upon dialysis was checked by dialyzing
twice (at 4◦C for 2 and 15 h, respectively) the supernatant
against 100 volumes of KM supplemented with 10% FCS
or against GKN solution (NaCl, 8 g/l; KCl, 0.4 g/l; glucose,
2 g/l; NaH2PO4, H2O, 0.69 g/l; Na2HPO4, 1.57 g/l; pH 7.2–
7.4) (Pérez et al., 2001) using a dialysis membrane with a
molecular weight cut-off of 3.5 kDa (Spectrum Laboratories).
The dialyzed supernatant was then filtrated through a 0.2µm
membrane and kept frozen at −80◦C prior to G. duodenalis
inhibition assays.
The biochemical nature of inhibitory molecule(s) was
investigated by preincubating the 5-fold concentrated
L. johnsonii La1 supernatant obtained by ultrafiltration (>10
kDa) with different enzymes coupled to beads. Briefly, proteinase
K (Invitrogen), pronase and catalase (Merck) were coupled
to CNBr-activated SepharoseTM 4B beads (GE Healthcare)
following manufacturer’s instructions. Five milliliters of the
5-fold concentrated L. johnsonii La1 supernatant or the
5-fold concentrated fresh control medium were incubated
for 6 h at room temperature (RT) in the presence of 100µl
of packed enzyme-coupled beads. Beads were removed by
centrifugation (4000 × g, 5min) before parasite growth
inhibition assays.
Measurement of Free Fatty Acids
To assess the presence of free fatty acids in the complex
medium inducingG. duodenalis growth inhibition, FCS, bile, and
L. johnsonii La1 supernatant were analyzed for non-esterified
fatty acid (NEFA) content either alone or in combination in
KM. Respective concentrations of the components in samples
were as follows: FCS 10% (v/v), bile 0.6 g/L and L. johnsonii
La1 supernatant 33.3% (v/v) final concentration in KM, pH
6. Samples (0.5ml) were kept on ice before being incubated
for 24 h at 37◦C in the presence of 4.8 × 104 trophozoites or
without parasites. At the end of the incubation period, tubes
were chilled on ice, centrifuged at 700 × g, 10min at RT. The
supernatants were then taken and frozen at −80◦C before NEFA
measurement. Numbers of living and “dead” trophozoites (as
defined above) were determined using a Malassez cell chamber.
NEFAs were quantified using the spectrometric NEFA-C kit
method, based on Duncombe (1964) and Itaya and Ui (1965)
studies, following manufacturer’s instructions. Oleic acid was
used as a standard and NEFAs were expressed as oleic acid
equivalents (Eq).
Bile Salt Hydrolase (BSH) Activity Assays
of Chromatography Fractions
After gel filtration, the eluted fractions were concentrated 10-fold
by dialysis against 20mM ammonium acetate buffer containing
2M sucrose, pH 6.0, using a 3.5 kDa molecular weight cut-off
membrane (Spectrum Laboratories). Bile salt GDC was used
for enzymatic assays. BSH activity was monitored by measuring
glycine liberation from conjugated bile salts following the
protocol described by Grill et al. (2000). Briefly 100µl of eﬄuent
fractions or 1 unit of BSH or elution buffer were mixed with
100µl of 2.4 g/l of GDC and incubated for 24 h at 37◦C. Controls
were performed in the absence of the bile salt. The enzymatic
reaction was stopped by addition of an equal volume of 15%
TCA. Precipitated proteins were pelleted by centrifugation at
20,000× g for 15min and the supernatant was carefully removed.
To 80µl of supernatant, 680µl of 0.3M borate buffer, 1% SDS,
pH 9.5 and 80µl of 0.3% picrylsulfonic acid solution (Sigma-
Aldrich) were added. The mixture was incubated for 30min in
the dark and 800µl of 1mMHCl was added to stop the reaction.
Glycine concentration was measured at 416 nm using an Uvikon
spectrophotometer 930 (Kontron Instruments). A standard curve
was established using free glycine (Sigma-Aldrich).
LC/ESI-MS Analysis of Modifications of
Bile Components by L. johnsonii La1
Supernatants
L. johnsonii La1 supernatant prepared in KM, pH 6.0,
supplemented with 10% FCS and 1 g/L bovine bile was incubated
overnight at 37◦C. Two different bile batches and two different
L. johnsonii La1 supernatant preparations were tested. Controls
constituted of KM alone and heat-treated L. johnsonii La1
supernatant (90◦C, 10min). The sample preparation and LC-
MS protocol were adapted from the conditions reported in
the literature on the LC-MS analysis of bile (Mitamura et al.,
2011) and bile acids (Perwaiz et al., 2001; Griffiths and Sjövall,
2010). After incubation, the samples were diluted 4-fold in
Milli-Q water and subjected to solid-phase extraction using
Oasis R© HLB cartridges (30mg solid phase). After conditioning
with 3ml methanol and 3ml Milli-Q water, the cartridges were
loaded with 1ml of the 4-fold diluted samples, washed with
2ml Milli-Q water and eluted with 2ml methanol. The eluted
fractions were vacuum dried and resuspended in 500µl Milli-Q
water/acetonitrile 90:10 (v/v). 5µl of each resuspended sample
was analyzed by liquid chromatography coupled electrospray
ionization-mass spectrometry (LC/ESI-MS) on an Ultimate
U3000 chromatographic system (Thermo Scientific) connected
to a Q-STAR Pulsar Qq-TOF mass spectrometer equipped with
an ionspray source (Sciex). The LC separation was achieved
by an Interchrom Strategy C18-2 micro column (5µm, 150 ×
1mm, 100 Å, Interchim). The elution gradient was 10% mobile
phase B (acetonitrile) to 70% B against mobile phase A (5mM
ammonium formate/formic acid, pH 6) over 45min, at a flow
rate of 40µl/min. The MS data were acquired in negative mode
in the range m/z 250–1200. Each LC/ESI-MS experiment was
conducted twice. Data-dependent LC/ESI-MS/MS experiments
were also conducted on each sample, alternating 1-s full-scan
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MS followed by 2-s product ion collision induced dissociation of
the major ions detected at the first step, using a −50 V collision
voltage.
The raw LC/ESI-MS data were converted into Network
Commun Data Form (NetCDF) using the translation tool
provided by Sciex and processed with the XCMS package (Smith
et al., 2006), a software implemented in the freely available R
environment (www.r-project.org). This analysis allows automatic
retention time alignment, matched filtration, peak detection, and
peak matching.
Proteomic Analysis of L. johnsonii La1
Supernatant
Sodium lauroyl sarcosinate (NLS, 0.1%, Sigma-Aldrich)
was added to L. johnsonii La1 supernatant. After mixing,
trichloroacetic acid (TCA) was added to a final 7.5%
concentration and the solution was precipitated on ice
overnight. Mixed protein-detergent precipitate was collected by
centrifugation (10,000 × g, 10min, 4◦C). The supernatant was
carefully removed and the pellet was washed twice with 2ml
of precooled tetrahydrofuran (Sigma-Aldrich). The pellet was
then resuspended in 8M urea in 20mM triethylammonium
bicarbonate and incubated for 1 h at 20◦C with 20mM DTT,
followed by incubation with 50mM iodacetamide for 1 h at
20◦C in the dark. The sample was incubated with 0.05 U
of endoproteinase Lys-C (Wako Pure Chemical Industries)
for 18 h at RT. Then, the samples were diluted with 20mM
triethylammonium bicarbonate to a final concentration of 1M
urea and trypsin (Promega) digestion was performed with
2µg of enzyme for 4 h at 20◦C and terminated with a final
concentration of 0.5% trifluoroacetic acid. The sample was
passed sequentially through two home-made Poros Oligo-R3
(PerSeptive Biosystems) microcolumns packed (∼1 cm) on p200
tips over 3MM C18 material plug. Loaded resin was washed
with 100µl 0.1% trifluoroacetic and peptides were eluted with
100µl 70% acetonitrile/ 0.1% trifluoroacetic, then 20µl 100%
acetonitrile. The desalted sample was dried down, resuspended
in 50% acetonitrile, dried, and stored at −80◦C. Part of the
sample (10%) was collected for amino acid analysis using a
Biochrom 30 amino acid analyzer.
Samples (3µg per run) were analyzed by an EASY-nano
LC system (Proxeon Biosystems) coupled online to an LTQ-
Orbitrap Velos mass spectrometer (Thermo Scientific). Peptides
were loaded onto a 18 cm fused silica emitter (75µm inner
diameter) packed in-house with reverse phase capillary column
ReproSil-Pur C18-AQ 3µmresin (Dr.MaischGmbH) and eluted
using a gradient from 100% phase A (0.1% formic acid) to
35% phase B (0.1 formic acid, 95% acetonitrile) for 180min,
35 to 100% phase B for 5min and 100% phase B for 8min (a
total of 23min at 250 nl/min). After each run, the column was
washed with 90% phase B and re-equilibrated with phase A. Mass
spectra were acquired in positive mode applying data-dependent
automatic survey MS scan and tandem mass spectra (MS/MS)
acquisition. Each MS scan in the orbitrap (mass range of m/z
of 400–1800 and resolution 100,000) was followed by MS/MS of
the 15 most intense ions in the LTQ. Fragmentation in the LTQ
was performed by collision-induced dissociation and selected
sequenced ions were dynamically excluded for 25 s.
Raw data were viewed in Xcalibur v.2.1 (Thermo Scientific)
and data processing was performed using Proteome Discoverer
v.1.3 (Thermo Scientific). The generated raw files were submitted
to searching using Proteome Discoverer with an in house Mascot
v.2.3 algorithm against a database of proteins predicted from the
L. johnsonii isolates NCC533 and FI9785 and the L. johnsonii
prophage Lj965 (http://www.ncbi.nlm.nih.gov/bioproject).
Contaminant proteins (human keratins, BSA and porcine
trypsin) were also added to the database and all contaminant
proteins identified were manually removed from the result lists.
The searches were performed with the following parameters:
ms accuracy 10 ppm, MS/MS accuracy 0.6 Da, trypsin digestion
with one missed cleavage allowed, fixed carbamidomethyl
modification of cysteine and variable modification of oxidized
methionine and N-terminal protein acetylation. The number of
proteins, protein groups, and number of peptides were filtered
for False Discovery Rates (FDR) less than 1%. Only peptides with
rank 1 and minimal of 2 peptides per protein were accepted for
identification using Proteome Discoverer (Charneau et al., 2007;
Queiroz et al., 2013).
Statistical Analyses
Significant differences between treatments were tested using the
“Kruskal-Wallis” test in http://marne.u707.jussieu.fr/biostatgv/.
Results were considered significant at P < 0.05.
RESULTS
The Anti-Giardia Growth Effect, Mediated
by L. johnsonii La1 Supernatant, is
Dependent upon Bovine Bile and More
Specifically upon Bile Salts
Pérez et al. (2001) showed that the inhibitory effect of L. johnsonii
La1 supernatant upon in vitro G. duodenalis growth was pH
dependent with a more pronounced inhibitory effect at pH
6 than pH 7. Change of culture medium pH had a slight
effect on parasite proliferation and adhesion properties. We thus
set up our culture assays at pH 6. FCS was used instead of
adult bovine serum for better reproducibility of the assay. In
our experimental conditions, parasite morphology, motility, and
viability measured by propidium iodide staining were unaffected
(Video S1, Figure S1).
Most media previously described to support G. duodenalis
growth in vitro commonly contains bile as a supply for
parasite cholesterol and fatty acid requirements (Farthing et al.,
1985; Gillin et al., 1986; Halliday et al., 1995). In our hands,
G. duodenalis trophozoites growth was observed in the absence
of bovine bile. Bile, at the recommended concentration (0.75 g/L)
(Pérez et al., 2001), appeared to reduce trophozoite proliferation
when added to KM-FCS (Figure 1A). We next confirmed the
in vitro inhibitory effect of L. johnsonii La1 supernatant upon
G. duodenalis growth. Interestingly, the inhibitory effect was only
observed in the presence of bovine bile. No inhibitory effect was
observed in the absence of bovine bile, even after 24 h of culture
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FIGURE 1 | (A) The inhibitory effect of L. johnsonii La1 supernatant on G.
duodenalis growth is observed after 24 h in the presence of bovine bile. G.
duodenalis trophozoites were grown in KM-FCS with bovine bile (0.75 g/L, final
concentration) in the presence () or in the absence () of bacterial
supernatant, or without bovine bile in the presence () or in the absence (♦) of
bacterial supernatant. The parasite concentration was estimated by counting
live cells with a Malassez cell chamber. Values are the mean ± SD of two
independent experiments performed in triplicate. Letters indicate significant
differences between treatments (Kruskall-Wallis, p < 0.05). (B) G. duodenalis
growth inhibition by L. johnsonii La1 supernatant depends on the presence of
bile, more specifically of bile salts. G. duodenalis trophozoites in KM-FCS were
incubated for 24 h with L. johnsonii La1 supernatant and various
concentrations of mixed bile salts (0.016, 0.032, 0.048 g/L, final concentration)
or complete bovine bile (0, 0.5, 0.6, 0.75 g/L, final concentration). Growth
inhibition values (%) were normalized according to controls in lactic
acid-acidified KM-FCS supplemented with similar concentrations of bovine bile
or mixed bile salts. Values are the mean ± SD of three independent
experiments. Letters indicate significant differences between treatments
(Kruskall-Wallis, p < 0.05).
(Figure 1A). After 10 h in the presence of 0.75 g/L of bovine
bile, G. duodenalis trophozoite survival was slightly impacted by
L. johnsonii La1 supernatant, but survival was largely affected
after 24 h of contact (9.104 and 1.104 trophozoite/ml, respectively,
Figure 1A, Video S2, Figure S1). Thus, a 24 h incubation time-
period was retained for all subsequent inhibitory growth assays.
Maximal inhibitory effects of L. johnsonii La1 supernatant on
parasite growth were observed either in the presence of 0.6 g/L
of complete bovine bile or in the presence of 0.032 g/L of bile
salt mix (96.3 and 75% of inhibition, respectively, by comparison
with control media containing the same amount of lactic acid,
bile or bile salt mix, Figure 1B, p < 0.05). Similar inhibitory
effects were observed using two isolates ofG. duodenalis (WB and
FIGURE 2 | G. duodenalis growth inhibition by L. johnsonii La1
supernatant is affected by supernatant incubation with proteases,
heat-treatment and pH. (A) Supernatant of L. johnsonii La1 was incubated
for 6 h with 1mg of immobilized proteases (L. johnsonii La1 supernatant: no
protease treatment; L. johnsonii La1 supernatant + PK: treatment with
proteinase K; L. johnsonii La1 supernatant + Pronase: treatment with pronase;
L. johnsonii La1 supernatant + Catalase: treatment with catalase) or heated at
90◦C for 10min before G. duodenalis growth inhibition assay. Growth inhibition
(%) was normalized according to matched control: lactic acid-adjusted MTYI
medium incubated with protease-coupled beads or treated for 10min at
90◦C. (B) Supernatant from L. johnsonii La1 in MTYI medium was adjusted to
pH 6.2, 6.7, 6.9, or 7.2 before Giardia growth inhibition assays. Growth
inhibition (%) was normalized according to control, i.e., lactic acid-adjusted
MTYI subsequently raised to pH 6.2, 6.7, 6.9, or 7.2. Values are the mean ±
SD of three independent experiments. (C) Molecular weight determination of
inhibitory compounds from L. johnsonii La1 supernatant. Supernatant from a
culture of L. johnsonii La1 in KM-FCS was filtrated through 10, 30, or 50 kDa
MW cut-off membranes. Acidified KM-FCS alone was processed similarly.
Fractions above and under respective thresholds were assayed for Giardia
growth inhibition in the presence of bile (0.5 g/L). Inhibition values (%) were
normalized according to KM-FCS controls. Data are the mean ± SD of three
independent experiments performed in triplicate. Letters indicate significant
differences between treatments (Kruskal-Wallis, p < 0.05).
HP1), two different commercial origins of complete bovine bile
(Figure S2) and two differentmedia compatible with bacteria and
parasite growth: MTYI (Pérez et al., 2001) and KM-FCS (Paget
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et al., 2004). Unless otherwise indicated, subsequent in vitro G.
duodenalis inhibition growth assays were performed using KM
as medium at pH 6 and 0.6 g/L of complete bovine bile.
Biochemical Characterization of Inhibitory
Activity
L. johnsonii Extracellular Products Inhibiting Giardia
Growth are of Peptidic Nature
To biochemically characterize the inhibitory activity present
in L. johnsonii La1 supernatant, the supernatant was treated
with immobilized enzymes prior to contact with parasites.
Trophozoite growth inhibition was totally abolished by
proteinase K and pronase treatments, suggesting involvement
of inhibitory factor(s) of peptidic nature (Figure 2A). Heat-
treatment also led to inactivation of L. johnsonii La1 supernatant
inhibitory properties (Figure 2A). Additionally, in a pH range
similar to the ones experienced by G. duodenalis in vivo (Biagini
et al., 2001), a strong pH influence on the inhibitory activity
was noticed, with the highest inhibition occurring at pH 6.2
(Figure 2B).
Moreover, Pridmore et al. (2008) demonstrated L. johnsonii
La1 supernatant anti-Salmonella activity was mediated by the
toxic effects of hydrogen peroxide (H2O2) and can be abolished
by pretreatment with catalase. Therefore, we checked whether
treatment of L. johnsonii La1 supernatant with catalase might
prevent its anti-Giardia activity. Catalase pretreatment only
slightly affected the inhibitory activity of L. johnsonii La1
supernatant on G. duodenalis (Figure 2A), invalidating the role
of H2O2 in Giardia growth inhibition.
To assess whether G. duodenalis growth inhibition by
L. johnsonii La1 supernatant might be due to toxic free fatty acids
as demonstrated forG. duodenalis killing by humanmilk (Rohrer
et al., 1986), FCS, bile, and L. johnsonii La1 supernatant were
analyzed for NEFA content either alone or in combination, using
the NEFA-C methodology (WAKO diagnostics). Then different
samples were incubated for 24 h at 37◦C with or without G.
duodenalis trophozoites and cell supernatants were analyzed for
NEFAs. Survival and growth of the parasites in those different
conditions were determined.
KM medium with FCS or L. johnsonii La1 supernatant,
displayed NEFA concentrations of 37.7 and 39.5µM (oleic
acid equivalents), respectively (Table 1). Co-incubation of bile
with serum led to increased NEFA concentration (101.2µM)
suggesting that the increasemight result from improved exposure
of protein-bound fatty acids from serum by the action of
bile acids, thus facilitating substrate (fatty acid) recognition by
enzymes from the NEFA kit. The highest concentration of NEFAs
(134.6µM) was measured upon co-incubation of FCS with bile
and L. johnsonii LA1 supernatant, as expected from summing
their respective NEFA contents. It was verified that the presence
of G. duodenalis had no noticeable effect on the NEFA content of
the various samples (Table 1).
From the results in Table 1, it can be noted that normal
parasite growth and survival (97.1%) observed in KM-FCS-bile
was totally inhibited by addition of L. johnsonii La1 supernatant
which induced 100% of parasite death, although the NEFA
concentration was increased by only 1.33X (i.e., from 101.2 to
134.6µM). This strongly suggested that NEFAs do not play
a prominent role in Giardia inhibition by L. johnsonii La1
supernatant.
L. johnsonii Extracellular Products Inhibiting Giardia
Growth are>10 kDa Factor(s)
Fractionation experiments of L. johnsonii La1 supernatant by
ultrafiltration using different molecular weight cut-offs indicated
that the L. johnsonii La1 supernatant inhibitory activity was due
to molecule(s) bigger than 10 kDa, since the fraction >10 kDa
showed a much higher G. duodenalis inhibition compared to the
fraction <10 kDa (around 70 vs. 20% inhibition, respectively,
p < 0.05, Figure 2C). By performing a 30 kDa threshold
fractionation, the inhibitory activity concentrated mostly in the
>30 kDa fraction (66% of Giardia growth inhibition, even if not
significantly different from the control, p > 0.05, Figure 2C),
however an inhibitory effect (∼40%) was also observed with
the <30 kDa fraction. A 50 kDa threshold fractionation of L.
johnsonii La1 supernatant was unable to segregate the inhibitory
activity, i.e., 50 and 48% of Giardia growth inhibition were
induced by<50 and>50 kDa fractions, respectively (Figure 2C).
Fractionation of L. johnsonii La1 supernatant was also realized
by dialysis using a 3.5-kDa cut-off membrane against KM-FCS
or GKN buffer (Pérez et al., 2001). Parasite killing activity of
L. johnsonii La1 supernatant in the presence of bile was fully
recovered after dialysis, whatever the dialysis solution, indicating
that no element crucial to the inhibitory activity was lost upon
dialysis (Table 2). All together, these data indicated that L.
johnsonii La1 supernatant factor(s) involved in the inhibitory
activity display molecular weight > to 10 kDa.
L. johnsonii La1 Supernatant Modifies Bile
Composition by Increasing Deconjugated
Bile Salts that are Toxic to Giardia
Since concomitant addition of bovine bile and L. johnsonii La1
supernatant to the culture medium leads to inhibition of G.
duodenalis growth, we assessed whether bile composition might
be modified by L. johnsonii La1 supernatant. Bile composition
was investigated by LC/ESI-MS after 24 h of incubation with L.
johnsonii La1 supernatant (Figures 3A,B). Impacted molecules
were identified by their m/z MS/MS fragmentation pattern and
comparison with standards. Comparison of bile salt profiles
showed a decrease of conjugated salts (GC, TC, GDC, TDC,
GCDC, TCDC) in favor of non-conjugated salts. C and DC were
the main statistically enhanced non-conjugated salts (Figure 4)
and in a minor proportion, CDC. These modifications were not
observed in presence of heat-treated L. johnsonii La1 supernatant
(Figure 3C).
The inhibition of G. duodenalis growth by pure bile salts
(C, DC, and CDC) conjugated to glycine or taurine, or their
deconjugated counterparts were investigated in the presence
or the absence of L. johnsonii La1 supernatant (Table 3). In
the absence of L. johnsonii La1 supernatant, glycyl-, or tauryl-
conjugated salts and deconjugated C showed no apparent toxicity
at the concentrations tested (IC50 values >400µM). In contrast,
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TABLE 1 | Involvement of non-esterified fatty acids in the G. duodenalis inhibition by L. johnsonii La1 supernatant.
Incubation medium NEFAs (µM Eq) in NEFAs (µM Eq) in the Survival rate (%) in the
presence of Giardia absence of Giardia presence of Giardia
KM 0 1.5±1.4 21.4 ± 15.7
KM + FCS 37.7±4.1 25.4±8.3 94.7 ± 4.3
KM + L. johnsonii La1 supernatant 39.5±6.8 37.4±17.3 50.0 ± 20.7
KM + FCS + bile 101.2±6.8 87.7±5.1 97.1 ± 2.7
KM + FCS + L. johnsonii La1 supernatant 66.4±4.2 60.1±15.7 91.7 ± 3.7
KM + FCS + bile + L. johnsonii La1 supernatant 134.6 ± 5.5 149.5 ± 16.8 0
The various components of the Giardia culture medium and L. johnsonii La1 supernatant were analyzed either alone or in combination for NEFA content after 24 h of incubation at
37◦C. Incubation was performed with or without Giardia trophozoites (4.8 × 104 / ml). At the end of the incubation period, survival and multiplication of the trophozoites in the different
conditions were determined. Trophozoite survival rate after 24 h of incubation was expressed as the (number of living trophozoites / total number of trophozoites) × 100. Values are the
mean ± SD from three independent experiments. It was verified that NEFA contents after 24 h of incubation at 37◦C were similarly independent of the presence of Giardia.
TABLE 2 | Dialysis through 3.5 kDa cut-off membrane does not inactivate the inhibitory activity of L. johnsonii La1 supernatant.
KM-FCS L. johnsonii L. johnsonii La1 supernatant L. johnsonii La1 supernatant
La1 supernatant dialyzed against KM-FCS dialyse against GKN
GROWTH INHIBITION ASSAY IN THE ABSENCE OF BOVINE BILE
Multiplication factor 3.8 3.2 3.7 2.4
Survival rate (%) 93.7 88.3 90.2 89.3
GROWTH INHIBITION ASSAY IN THE PRESENCE OF BOVINE BILE
Multiplication factor 2.3 1.2 1.5 0.8
Survival rate (%) 92.9 0 0 0
L. johnsonii La1 supernatant was dialyzed against GKN buffer or KM-FCS and then tested for G. duodenalis trophozoite growth in the presence or absence of bovine bile (0.5 g/L).
Non-dialyzed KM-FCS and L. johnsonii La1 supernatant were used as controls. Parasite multiplication factor was expressed as the number of total trophozoites / number of trophozoites
at time zero of incubation. Trophozoite survival rate was expressed as the (number of living trophozoites / total number of trophozoites) × 100. Values are the mean of two independent
experiments performed in duplicate.
deconjugated DC, and CDC exhibited inhibitory effects on
trophozoite growth with IC50 values of 132µM (DC) and
147µM (CDC). Interestingly, in the presence of L. johnsonii La1
supernatant, the conjugated bile salts IC50 values fell to a range
of values similar to those measured for their pure deconjugated
counterparts, i.e., 104 (GDC), 79 (TDC), 110, (GCDC), and
115µM (TCDC) (Table 3).
These results suggested that a deconjugating process mediated
by L. johnsonii La1 supernatant component(s) and production
of deconjugated bile salts might be responsible for the inhibitory
effect of the association of bile with L. johnsonii La1 supernatant.
Such a hypothesis is in line with the previous observation that
fusidic acid, an antibiotic with a bile salt-like chemical structure,
is toxic to Giardia (see Table 3, IC50value = 26µM) unless
conjugated to taurine or glycine (Farthing and Inge, 1986).
Potential Involvement of L. johnsonii La1
Bile-Salt Hydrolase(s) Activity in
Bile-Mediated Giardia Inhibition
Correlation between Bile Salt Hydrolase Activity and
Anti-Giardial Properties after Fractionation of
Extracellular Products
It is known that the bile salt deconjugating process is mediated
by 3-alpha, 7-alpha, 12-alpha-trihydroxy-5-beta-cholan-
24-oylglycine / taurine amidohydrolases (EC 3.5.1.24), also
named choloylglycine / taurine hydrolases, conjugated bile acid
hydrolases (CBAH), or BSH (Nair et al., 1967). These enzymes
act on non-peptide carbon-nitrogen bonds, specifically in linear
amides, releasing glycine and taurine from conjugated bile salts.
Three genes (LJ0056, LJ1147, and LJ1412) encoding BSH-like
enzymes have been predicted in the genome of L. johnsonii
(Morrison et al., 2007). These enzymes are also predicted to
be secreted, as indicated using SecretomeP (predictions of a
non-classical i.e., not signal peptide triggered protein secretion),
with theoretical full sizes of 34.9, 36.3, and 36.6 kDa and secreted
sizes of 29.8, 31.0, and 31.3 kDa, respectively.
To test the hypothesis of bacterial BSH involvement in the
inhibitory activity of L. johnsonii La1 supernatant, the bacterial
supernatant was fractionated by gel filtration chromatography
on a Sephacryl S300 column, and eluted fractions were assayed
for both parasite inhibition and bile salt deconjugating activity.
A typical elution profile is shown in Figure 5A. Fractions were
collected, tested forG. duodenalis growth inhibition and for BSH-
like activity by measuring release of glycine from GDC. In our
experimental conditions, 1 unit of the commercial C. perfringens
BSH induced the release of 0.76mM glycine from 2.5mM GDC
within 24 h. Parasite growth inhibitory activity was reproducibly
recovered from the first eluted fractions containing proteins
with molecular weight between 13.7 and 67 kDa (Figures 5A,C)
confirming the estimate of the molecular weight of the
inhibitory factor(s) to be >10 kDa (Figure 2C). Those active
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FIGURE 3 | Impact of L. johnsonii La1 supernatant on bovine bile composition. Total ion chromatograms detected by LC-MS of the treated samples
corresponding to incubation of bile for 24 h at 37◦C with either (A) KM alone, (B) KM + L. johnsonii La1 supernatant or, (C) KM + heat-treated L. johnsonii La1
supernatant (10min, 90◦C). TC, taurocholate; GC, glycocholate; TCDC, taurochenodeoxycholate; TDC, taurodeoxycholate; GCDC, glycochenodeoxycholate; GDC,
glycodeoxycholate; C, cholate; CDC, chenodeoxycholate; and DC, deoxycholate.
fractions also exhibited a BSH-like activity (Figure 5B), with
the most inhibitory fractions showing significantly higher BSH-
like activity (p < 0.05). Our attempts to further purify elements
responsible for the inhibitory activity and/or BSH-like activity by
combining steps of ion-exchange, hydrophobic interaction and
chromatofocusing chromatographies were unsuccessful, with a
rapid loss of activities.
Active Clostridium perfringens BSH in Presence of
Tauryl and Glycyl-Bile Salts Mimics the Anti-Giardial
Activity of L. johnsonii Extracellular Fractions
To assess the capability of BSH enzymes to promote the
bile-mediated anti-Giardia effect, BSH from the bacteria C.
perfringens was tested for G. duodenalis growth inhibition in
the presence of bile or pure conjugated bile salts. As notified
(Table 3), glycine or taurine conjugated bile salts, TDC, TCDC,
GDC, and GCDC have no inhibitory activity on G. duodenalis
growth in KM-FCS. In contrast, the addition of C. perfringens
BSH to the culture in the presence of the conjugated bile salts led
to a remarkable parasite inhibition within the 24 h of the assay,
with inhibition ranges of 95–100% depending on the conjugated
bile salt (Figures 5B, 6). Heat inactivation of C. perfringens BSH
(100◦C, 5min) dramatically reduced or even abolished its anti-
Giardia activity (less than 20% growth inhibition depending
on the conjugated bile salts tested, Figure 6) indicating
that parasite growth inhibition depends on BSH enzymatic
activity.
Evidence for the Presence of at least two BSH-Like
Enzymes in the L. johnsonii La1 Supernatant
We investigated whether the BSH-like enzymes annotated from
L. johnsonii La1 genome and predicted to be secreted are
indeed released into the bacterium culture medium. High-
resolution mass spectrometry-based proteomic analysis of L.
johnsonii La1 extracellular proteins was performed. Three micro
gram of proteins from two independent culture supernatants
allowed high-confidence identification of 1787 and 1746
peptides (FDR<1% at peptide level and only rank 1 peptide
identification) providing a total of 164 and 166 protein groups
with a minimum of 2 high-confidence peptides per protein,
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FIGURE 4 | Increase of the non-conjugated salts cholate and deoxycholate content after treatment of bovine bile with L. johnsonii La1 supernatant.
(A) Structures of cholate ([M-H]- at m/z 407, left side) and deoxycholate ([M-H]- at m/z 391, right side). (B,C) Corresponding extracted ion chromatograms (B) and
peak area boxplot (C) obtained from bile samples incubated with KM (in black) or L. johnsonii La1 supernatant (in red).
respectively (Table S1) and 147 common proteins between the
two replicates (Figure S2). Amongst them, two of the three
predicted BSHs, LJ1412 (gi|41583570), and LJ1147 (gi|41583360),
were clearly identified by an untargeted/undirected approach in
both replicates (Table 4).
DISCUSSION
Probiotics constitute promising protective alternatives against
pathogens, at least as prophylactic agents in various diseases
or when used in combination with other therapeutic agents,
through a variety of mechanisms relying on immunomodulation
properties, competition for nutrients, and habitats, and secretion
of active molecules (e.g., antimicrobial peptides, bacteriocins,
antibiotics, free fatty acids, hydrogen peroxide; For reviews,
Britton and Versalovic, 2008; Travers et al., 2011). In the
context of Giardia infections, a number of studies pointed out
the importance of the microbiota and the potential role of
probiotics in preventing infection and development of disease
(Singer and Nash, 2000; Humen et al., 2005; Shukla et al., 2008,
2012; Shukla and Sidhu, 2011; Goyal et al., 2013; Goyal and
Shukla, 2013). L. johnsonii La1 (NCC533), Lactobacillus casei
MTCC1423, and E. faecium SF68 were consistently identified
throughout these studies. In in vivo experiments, those strains
were shown to prevent parasite-induced intestinal damage and
decrease duration and severity of giardiasis (Humen et al., 2005;
Shukla et al., 2008, 2012; Shukla and Sidhu, 2011). Moreover,
Pérez et al. (2001) reported inhibitory activity of L. johnsonii
La1 on in vitro growth of G. duodenalis trophozoites. A partial
characterization of the factors involved in the anti-giardial
action indicated heat-inactivable low-molecular weight (<1 kDa)
components.
Based on this evidence and the potential of probiotics
to regulate Giardia proliferation, we aimed to decipher the
molecular mechanisms involved in the in vitro anti-giardial
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FIGURE 5 | Inhibitory activity against G. duodenalis growth and BSH-like activity co-elute in the same fractions after separation of L. johnsonii La1
supernatant by gel filtration chromatography. (A) Chromatography profile. (B) BSH-like activity measured after 24 h of incubation of GDC with the 6 first eluated
gel filtration fractions. (C) G. duodenalis growth inhibitory activity after 24 h of incubation with the same gel filtration chromatography fractions as in B. Letters indicate
significant differences between treatments (Kruskal-Wallis, p < 0.05).
activity of L. johnsonii La1. In an experimental assay similar
to that published by Pérez et al. (2001), we were able to
confirm that L. johnsonii La1 supernatants significantly inhibit
the proliferation of different strains of G. duodenalis in vitro.
Pérez et al. (2001) showed that the inhibitory effect of L.
johnsonii La1 supernatant upon G. duodenalis growth was pH
dependent with a more pronounced inhibitory effect at pH 6
than pH 7. Inhibitory assays were thus performed at pH 6
instead of pH 6.8–7, the pH normally used for Giardia culture.
The pH change had a slight effect on parasite proliferation
and adhesion properties (Pérez et al., 2001). We also observed
no effect on the parasite morphology, motility and viability
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TABLE 3 | Conjugated bile salts in association with L. johnsonii La1
supernatant as well as deconjugated bile salts prevent the growth of G.
duodenalis.
KM + FCS IC50 KM + FCS + L. johnsonii
(µM) La1 supernatant IC50 (µM)
C Cholate >400 >400
GC Glycocholate >400 >400
TC Taurocholate >400 >400
DC Deoxycholate 132 ± 13 117 ± 13
GDC Glycodeoxycholate >400 104 ± 13
TDC Taurodeoxycholate >400 79 ± 17
CDC Chenodeoxycholate 147 ± 15 118 ± 22
GCDC Glycochenodeoxycholate >400 110 ± 11
TCDC Taurochenodeoxycholate >400 115 ± 8
FA Fusidic acid 26 ± 4 nd.
IC50 estimations. Various concentrations of taurine—and glycine-conjugated and
unconjugated C, DC and CDC bile salts were tested for G. duodenalis trophozoite growth
inhibition in KM-FCS in the presence or absence of L. johnsonii La1 supernatant. IC50
values were determined from drug-response curves and expressed as mean ± SD of at
least three independent experiments. nd.: not determined.
FIGURE 6 | G. duodenalis growth is inhibited by enzymatically active C.
perfringens BSH in the presence of conjugated bile salts (0.2 g/L).
Commercial C. perfringens BSH, enzymatically active or heat-inactivated
(100◦C, 5min) was added to G. duodenalis culture medium in the presence of
either GDC, glycodeoxycholate; GCDC, glycochenodeoxycholate; TDC,
taurodeoxycholate or TCDC; taurochenodeoxycholate. Values are the mean ±
SD of at least three independent experiments. Letters indicate significant
differences between treatments (Kruskall-Wallis, p < 0.05).
(Video S1, Figure S1). Furthermore, to avoid an inhibitory
activity due to the acidification with lactic acid produced
by L. johnsonii La1, bacteria supernatants were neutralized
before the assays and appropriate controls were prepared by
adding equivalent of lactic acid to fresh medium before pH
adjustment.
Using biochemical fractionations and assays, we were able to
document the properties of an active component present in the
L. johnsonii La1 supernatant that is inhibitory toward Giardia
trophozoites. We first showed that this active(s) component(s)
is lactic acid-independent, does not rely on free fatty acids,
and is distinct from H2O2. By using dialysis, ultrafiltrations
and combinations of enzymes, we showed that this active(s)
component(s) is of peptidic nature, thermosensitive and has a
molecular weight >10 kDa. We also demonstrated correlations
between this active(s) component(s) inhibiting Giardia and (1)
production of deconjugated bile salts toxic to Giardia and (2)
BSH activity(ies) of bacterial origin. However, since lactobacilli
are known to secrete a large variety of molecules (Lebeer et al.,
2008; Cicenia et al., 2014) that could act in concert to bring this
antimicrobial effect, and since the active component evidenced
by Perez was <1 kDa, we cannot exclude the existence of other
factors, secreted or released by L. johnsonii La1, that might also
contribute to Giardia inhibition.
We bring here a body of evidence strongly suggesting BSH-
like activities in the anti-giardial effect: (1) we observed a
conversion of conjugated bile salts into their toxic deconjugated
counterparts by L. johnsonii La1-supernatant, (2) a similar effect
was mimicked by purified Clostridium BSH, (3) we identified
two BSHs in L. johnsonii La1 supernatant by mass spectrometry
and (4) we measured BSH-like activities in the L. johnsonii
La1 fractionated supernatant, with the most enzymatically active
fractions mediating the highest toxicity to Giardia.
BSHs (EC 3.5.1.24) are bacterial enzymes known to hydrolyze
the amide bond in the C24 position of a wide variety of
conjugated bile salts, releasing a deconjugated salt and a taurine
or glycine residue (For review, Begley et al., 2006). BSHs are
mainly expressed by Gram+ bacteria such as Lactobacillus,
Bifodobacterium and Enterococcus species, although some species
do not express them. BSH activity allows for the detoxification
of conjugated bile salts, which are amphipathic molecules with
surfactant properties that can be toxic toward bacterial cells (De
Boever and Verstraete, 1999). It is believed that bacterial BSH
production is involved in the maintenance of their environment,
notably in the small intestine (for the probiotic strains) where
bile concentration is at its highest (Begley et al., 2006). This is
the first proposal for bacterial BSH activity regulating parasite
survival. Formal identification of the specific BSH(s) implicated
in this phenomenon is required. This may be accomplished by
recombinant protein production and/or invalidation of the L.
johnsonii La1 BSH genes (Pridmore et al., 2004). As previous
enzymatic studies on BSHs revealed that they may have distinct
affinities and specificities for glyco- or tauro- conjugates (For
review, Ridlon et al., 2006), it is important to define whether anti-
Giardia activity is mediated by a single type of BSHwith a defined
specificity, or by several BSH enzymes with mixed specificities.
BSHs from human intestinal lactobacilli usually have the highest
affinity for glycine conjugates (Ridlon et al., 2006).
We demonstrate here a two-step mechanism in which a
probiotic transforms bile components that could be toxic for itself
into components that are toxic to Giardia trophozoites. Giardia
tolerance to conjugated bile salts in vitro for concentrations
that are toxic to mammalian cell cultures relies on transport-
mediated processes (Halliday et al., 1995). At least two distinct
uptake mechanisms have been described, one Na+-dependent
and thiol blocker sensitive for cholyltaurine and the other
one Na+- and thiol blocker insensitive for cholylglycine. Both
uptake mechanisms are counterbalanced by a rapid eﬄux
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mechanism regulating the intracellular concentration of these
detergents to below their toxicity to Giardia (Das et al.,
1997). No biotransformation of conjugated bile salts into
their deconjugated counterparts by Giardia was observed. The
authors suggested that intracellular bile salts may facilitate
lipid trafficking and membrane biosynthesis in Giardia. Indeed,
Giardia lipid-binding proteins have been shown to have higher
affinity for bile salts than fatty acids, suggesting that lipids
are incorporated by these binding proteins more readily inside
the micelles formed by bile salts than by free fatty acids (de
la Guardia et al., 2011). Studies also suggest that conjugated
bile salts have a role in promoting Giardia encystation (Gillin,
1987; Gillin et al., 1989), a vital step in the parasite life
cycle that enables parasite survival outside of its host. It
could be of interest to find out whether such mechanisms can
also act on the parasite development cycle (encystation and
cyst properties). In this study, experiments were performed
using bovine bile instead of using human bile as both
species have similar proportions of cholic, desoxycholic, and
chenodesoxycholic acids. Besides, human, and bovine bile exhibit
an equivalent ratio of glycoconjugated bile salts over their
tauroconjugated counterparts (3:1) (Zhong et al., 1998). It can
thus be expected a similar inhibitory activity with human
bile.
Several studies mentioned briefly the toxic effect of
deconjugated bile salts on Giardia (Farthing et al., 1983,
1985, 1987; Gillin, 1987). To our knowledge, our study is the first
to demonstrate their dose-dependent anti-giardial activity. Their
IC50 values are lower than their critical micellar concentrations,
indicating that parasite killing is not related to their surfactant
properties (e.g., IC50 value for chenodeoxycholate = 0.15mM
and a critical micellar concentration >7 mM according to
the manufacturer). Their mechanism of action remains to
be deciphered. Interestingly, their inhibitory activity seems
dependent of their hydrophobic properties. No inhibition was
observed with the most hydrophilic salt, cholate (IC50 value
>400µM), unlike the more hydrophobic salts, deoxycholate
and chenodeoxycholate (IC50 values of 132 and 147µM,
respectively). Our results are in line with the previous
observation that the bile salt-like antibiotic, fusidic acid, is
toxic to Giardia (Farthing and Inge, 1986), which we confirmed
(IC50 = 26µM). However, its taurine and glycine conjugates
stimulate parasite growth at low concentrations, while modest
growth inhibition occurred at higher concentrations.
In conclusion, we demonstrate that the inhibitory effect
exerted in vitro by L. johnsonii La1 supernatant on Giardia
growth (1) is dependent on the presence of bile in the growth
medium, more precisely bile salts, (2) relies on molecules
released by L. johnsonii La1 that are of peptidic nature with
a molecular weight >10 kDa, (3) is due to the conversion of
conjugated bile salts into deconjugated bile salts that are toxic
to Giardia, (4) correlates with the presence and activity of BSH-
like enzymes from bacterial origin and (5) can be reproduced
by addition of C. perfringens BSH to the culture medium. These
experimental results point out that BSHs released by L. johnsonii
La1 would be main facilitators of this anti-parasitic effect. These
discoveries open a novel field to fight Giardia based on the
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use of deconjugated bile salts, chemically related drugs or by
administration of BSH-releasing probiotic strains.
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